A detailed history of Westmount Partners, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Westmount Partners, LLC holds 2,405 shares of NVO stock, worth $199,783. This represents 0.06% of its overall portfolio holdings.

Number of Shares
2,405
Previous 2,126 13.12%
Holding current value
$199,783
Previous $253 Million 18.28%
% of portfolio
0.06%
Previous 0.08%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 13, 2025

BUY
$85.0 - $120.04 $23,715 - $33,491
279 Added 13.12%
2,405 $207 Million
Q3 2024

Jan 13, 2025

BUY
$119.07 - $145.42 $253,142 - $309,162
2,126 New
2,126 $253 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $188B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Westmount Partners, LLC Portfolio

Follow Westmount Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Westmount Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Westmount Partners, LLC with notifications on news.